The FDA accepts a new drug application for vepdegestrant, a promising oral PROTAC developed by Arvinas and Pfizer, signaling ...

First Patient Dosing Expected in Q1 2026 • Clinical Trial to Prioritize Biomarker-Selected RBM39-Dependent Cancers KING OF ...

A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US Food and Drug Administration (FDA) accepted GSK’s gepotidacin for priority ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

Alzinova AB (publ) (Nasdaq First North: ALZ) today announced that the company has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for the planned P ...

The new initiative, FDA PreCheck, was developed in response to President Donald Trump’s executive order to accelerate the ...

Enrollment in the planned second dose expansion cohort completed ahead of expectationsTopline results expected in Q1 2026 ...

Total revenues of $301,000 for quarter, and $818,000 for first six months of 2025, from sales and collaborative research agreement - ...

British drugmaker GSK said on Monday its supplemental new drug application for antibiotic drug gepotidacin has been accepted for priority review by the U.S. Food and Drug Administration for the oral ...

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...

Adam Kovalčík, a 19-year-old from Slovakia, secured a top prize at an international science competition. He developed a ...

Amid a series of legal challenges, the Trump administration is asking the U.S. Supreme Court to take up a case on the federal ...